Cardiovascular disease in the dialysis population: prognostic significance of arterial disorders.
about
Imbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: a potential pharmacological targetEvolution of Cardiovascular Disease During the Transition to End-Stage Renal Disease.Systolic blood pressure and mortality in patients on hemodialysis.Association between environmental particulate matter and arterial stiffness in patients undergoing hemodialysisArterial stiffness and walk time in patients with end-stage renal diseaseSecreted klotho and chronic kidney diseaseDiagnosis and treatment of peripheral arterial disease in CKD patients.Update and critical appraisal of sevelamer in the management of chronic renal failure.Cardiorenal syndrome: acute kidney injury secondary to cardiovascular disease and role of protein-bound uraemic toxins.Abnormal ankle-brachial index and risk of cardiovascular or all-cause mortality in patients with chronic kidney disease: a meta-analysis.Increased nitric oxide production in platelets from severe chronic renal failure patients.Blood Pressure and Risk of Cardiovascular Events in Patients on Chronic Hemodialysis: The CRIC Study (Chronic Renal Insufficiency Cohort).Association between Low Serum Bicarbonate Concentrations and Cardiovascular Disease in Patients in the End-Stage of Renal Disease.Effect of a rosmarinic acid supplemented hemodialysis fluid on inflammation of human vascular endothelial cellsHepatocellular carcinoma in uremic patients: is there evidence for an increased risk of mortality?Arterial micro-calcification of vascular access is associated with aortic arch calcification and arterial stiffness in hemodialysis patients.Plain pelvic/aorta radiographs as a simple guideline to predict vascular macro-calcifications; one step earlier or a late sign to best weight the enemy of coronary calcification and mortality?Mortality and Low Serum Bicarbonate Level in Patients on Hemodiafiltration versus Peritoneal Dialysis.Therapeutic use of the phosphate binder lanthanum carbonateCardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome
P2860
Q26864722-1088480A-A0E4-4A5E-B4C9-F9E65D24A7E3Q30234797-308BB414-94D0-48F8-8AC3-621887268168Q34020784-A484FF1E-490E-4A2B-89D0-3EE4D03489B2Q36130786-D82A2622-F706-4535-897B-CB76F81AC686Q37013455-CA511BED-C38E-4CFC-8B30-825111A81B73Q37190542-F4E1B216-FC4A-4D42-B875-B1EE8A303546Q38052160-05A83061-8D19-48EC-BE30-3407A009CA37Q38160473-B661224C-A512-493E-9C56-A6827BC1756EQ38218395-B1F4CD53-E2C8-4582-8618-79B9A744BC0DQ39136047-3FBC38D3-DF8F-408F-A5F2-E922713D252DQ39782384-F9D8484B-4C8F-481F-ABBF-9E02CBDD23E2Q40136202-ABD36255-891A-4FBD-983C-6D9970C550ABQ42226773-4512C91B-9D73-4DAA-ACEC-EB5E71F09069Q42660367-3E7F49EB-16F5-4C57-B267-0431F10A7E31Q44111590-001B6EE9-E203-4BBB-8631-D741F50D1373Q45771808-38B41713-B8D8-4AB6-ACBE-09BC6C8A0B2FQ47276442-8C6251F4-7C64-4394-87A8-0CFB38521A0DQ54937510-7E8BB6AB-0AA1-4946-9F44-B65AFB6F6E3DQ57220755-258C685D-E126-4D69-964C-2704E8EE9457Q58773641-5335DCB4-08B3-445F-AC8E-62054D658992
P2860
Cardiovascular disease in the dialysis population: prognostic significance of arterial disorders.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Cardiovascular disease in the ...... ficance of arterial disorders.
@ast
Cardiovascular disease in the ...... ficance of arterial disorders.
@en
type
label
Cardiovascular disease in the ...... ficance of arterial disorders.
@ast
Cardiovascular disease in the ...... ficance of arterial disorders.
@en
prefLabel
Cardiovascular disease in the ...... ficance of arterial disorders.
@ast
Cardiovascular disease in the ...... ficance of arterial disorders.
@en
P2093
P1476
Cardiovascular disease in the ...... ficance of arterial disorders.
@en
P2093
Alain P Guérin
Bruno Pannier
Gérard M London
Sylvain J Marchais
P304
P356
10.1097/01.MNH.0000203186.11772.21
P577
2006-03-01T00:00:00Z